TipRanks
Go Ultimate55% OFF

QDM International (QDMI) AI Stock Analysis

QDMI

QDM International

(Other OTC:QDMI)

Select Model
Rating:77Outperform
Price Target:$11.50â–²(11.65% Upside)
Action:upgraded
Date:09/17/26

The score is driven primarily by strong profitability/growth and a very low-leverage balance sheet, supported by an attractive low P/E valuation. Offsetting these positives are negative TTM operating/free cash flow (a key earnings-quality risk) and technicals that are strong short-term but still weak versus longer-term moving averages.

Positive Factors
Revenue growth and profitabilityStrong recent revenue growth alongside high gross, operating, and net margins indicates that QDMI is scaling while retaining substantial economics from its products. If maintained, this profitability can support reinvestment, strengthen resilience, and expand earnings capacity over the next several quarters.
Negative Factors
Negative cash conversionNegative operating and free cash flow creates a meaningful gap between reported earnings and cash generation. If this persists, QDMI may have less internally generated funding for investment and operations, while working-capital timing could make near-term financial performance less reliable.

QDM International (QDMI) vs. SPDR S&P 500 ETF (SPY)

-100%0%100%200%300%400%QDMI-39.41%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$88.95M
Dividend Yield
―
Average Volume (3M)
2,438
Price to Earnings (P/E)
10.5
Beta (1Y)
1.09
Revenue Growth
138.89%
EPS Growth
28.39%
Country
US
Employees
9
Sector
Financial
Sector Strength
68
Industry
Insurance - Brokers

QDM International Business Overview & Revenue Model

Company Description

QDM International Inc. operates as an insurance brokerage firm, primarily serving the Hong Kong market. The company delivers a broad spectrum of insurance solutions, including personal protection plans such as individual life and health coverage. Its...

How the Company Makes Money

QDMI primarily makes money by selling and supporting its sample-preparation solutions used in molecular biology and molecular diagnostics workflows. Key revenue streams typically include: (1) sales of automated DNA extraction instruments and related...

QDM International Financial Statement Overview

Summary

Strong profitability and growth (TTM revenue +22.339% with high margins) and a very conservative balance sheet (TTM debt-to-equity ~0.01, strong recent ROE). The main drag is quality of earnings: TTM operating cash flow and free cash flow are both negative (~-$2.0M), creating a notable cash-conversion risk despite strong net income.

Income Statement

86Very Positive

Balance Sheet

90Very Positive

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue26.27M21.48M8.38M6.37M1.13M68.97K
Gross Profit12.82M11.51M7.32M2.45M416.39K133
EBITDA10.38M9.15M5.96M1.91M53.82K-376.50K
Net Income8.49M7.53M4.82M1.56M44.55K-378.17K
Balance Sheet
Total Assets21.13M17.44M10.71M5.78M3.15M270.64K
Cash, Cash Equivalents and Short-Term Investments10.16M10.33M8.56M5.16M2.72M69.66K
Total Debt266.06K71.38K186.51K199.28K73.80K111.35K
Total Liabilities1.60M1.07M1.87M2.36M1.34M944.62K
Stockholders Equity19.53M16.37M8.84M3.42M1.81M-673.97K
Cash Flow
Free Cash Flow-2.01M1.77M4.08M2.12M-5,690-402.31K
Operating Cash Flow-2.01M1.77M4.08M2.21M11.81K-398.61K
Investing Cash Flow-282.05K00-100.00K-17.50K-3,700
Financing Cash Flow40.00K0-683.22K332.89K2.65M436.36K

QDM International Technical Analysis

Technical Analysis SentimentPositive
Last Price10.30

Price Trends

50DMA8.72Positive
100DMA8.65Positive
200DMA27.63Negative

Market Momentum

MACD0.43Positive
RSI64.49Neutral
STOCH17.50Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For QDMI, the sentiment is Positive. The current price of 10.30 is above the 20-day moving average (MA) of 10.07, above the 50-day MA of 8.72, and below the 200-day MA of 27.63, indicating a neutral trend. The MACD of 0.43 indicates Positive momentum. The RSI at 64.49 is Neutral, neither overbought nor oversold. The STOCH value of 17.50 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QDMI.

QDM International Risk Analysis

QDM International disclosed 44 risk factors in its most recent earnings report. QDM International reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

1 New Risk
1.If we fail to comply with Hong Kong regulations on referral arrangements and benchmark referral fees, we may be subject to regulatory sanctions, including suspension or revocation of our insurance broker license, and our business, financial condition and results of operations could be materially and adversely affected.Q3, 2025

QDM International Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

QDMI against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
QDMIQDMI77Outperform$88.95M10.5159.55%―138.89%28.39%
HUIZHUIZ68Neutral$22.74M0.286.41%―――
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
SLQTSLQT59Neutral$64.00M-5.9510.03%―6.02%-144.93%
EZRAEZRA44Neutral$3.44M-0.09-88.14%―-21.45%82.28%
EHTHEHTH41Neutral$15.76M-0.593.23%―-8.37%-220.33%
ZBAOZBAO41Neutral$2.28M-0.03-424.23%―37.29%-396.20%

* Financial Sector Average

Performance Comparison

-100%0%100%200%300%QDMIEHTHEZRAHUIZSLQTZBAODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
QDMI and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
QDMIQdm International Inc.10.30-6.70-39.41%
EHTHEhealth0.49-4.69-90.50%
EZRAReliance Global Group2.05-36.49-94.68%
HUIZHuize Holding Ltd.2.25-1.45-39.19%
SLQTSelectQuote Inc0.36-1.70-82.67%
ZBAOZhibao Technology Inc. Class A0.26-50.24-99.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 17, 2026